BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12612656)

  • 1. Translational approaches to improving cervical screening.
    Baldwin P; Laskey R; Coleman N
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of screening tests for cervical cancer and its precancerous lesion].
    Zhao FH; Rong SD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New technologies in gynecologic cytology.
    Bishop JW; Marshall CJ; Bentz JS
    J Reprod Med; 2000 Sep; 45(9):701-19. PubMed ID: 11027079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How technology and vaccination have changed the Pap test].
    Bondi A; Ghidoni D; Amadori A
    Pathologica; 1999 Feb; 91(1):36-41. PubMed ID: 10396949
    [No Abstract]   [Full Text] [Related]  

  • 9. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in cervical screening technology.
    Stoler MH
    Mod Pathol; 2000 Mar; 13(3):275-84. PubMed ID: 10757338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
    de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
    Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of cervical cancer: where do we go from here?
    Kuo DY; Goldberg GL
    Cancer Invest; 2003; 21(1):157-61. PubMed ID: 12643017
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormal pap smears in adolescents.
    Bacon J; Francoeur D; Goldfarb AF; Breech LL
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):157-66. PubMed ID: 12804941
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E; Le Galès C; Cochand-Priollet B; Cartier I; de Crémoux P; Vacher-Lavenu MC; Vielh P; Coste J
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and cervical cancer screening. Recent advances improve the clinical picture.
    Berman NR
    Adv Nurse Pract; 2002 Oct; 10(10):26-35; quiz 35-6. PubMed ID: 12424881
    [No Abstract]   [Full Text] [Related]  

  • 19. Cervical cancer screening today. The role of HPV DNA testing.
    Berman NR
    Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of screening using cervicography in dysplasia and neoplasms of the uterine cervix].
    Coibion M; Guenier C; Miloiu A; Andry M; Bonnal JL; Nogaret JM
    Rev Med Brux; 1990; 11(1-2):16-20. PubMed ID: 2406832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.